Michael Weber, MD
Enriched profileProfessor of Medicine, Division of Cardiovascular Medicine, SUNY Downstate Health Sciences University · SUNY Downstate Health Sciences University
Michael Weber is Professor of Medicine, Division of Cardiovascular Medicine, SUNY Downstate Health Sciences University at SUNY Downstate Health Sciences University. OpenAlex indexes 997 publications with 49,925 citations (h-index 93); ClinicalTrials.gov lists 4 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 1% of Clinical Cardiac Electrophysiology profiles in the findmyKOL directory.
Data verified 25 Aug 2026
Overview
Updated 14 Oct 2026
Michael A. Weber, MD, is Professor of Medicine, Division of Cardiovascular Medicine, SUNY Downstate Health Sciences University. The public record shows 997 publications with 49,925 citations (h-index 93), centered on Hypertension. It also documents an investigator role on 4 registered clinical trials, industry payments reported by 45 companies.
- Most recent indexed publication: 2026 · Journal of the American Heart Association
- Top research focus: Hypertension
- 4 registered trials on ClinicalTrials.gov
- Open Payments reporting from 45 companies
Generated from the cited public record · current as of 14 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 28 in PubMed.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingFederally funded research awards.
Public positions
sourced statements on record- Member/consultant
Cardiovascular and Renal Drugs Advisory Board, U.S. Food and Drug Administration
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →downstate.edu ↗
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 14 Oct 2026
Listed as an investigator on 4 registered studies on ClinicalTrials.gov. The most recent:
- Renal Artery Denervation Assessment Without Antihypertensive Medication Regimen (RADAR)
Sponsor: Ablative Solutions, Inc.
- TARGET BP I Clinical Trial
Sponsor: Ablative Solutions, Inc.
- Renal Denervation Using the Vessix Renal Denervation System for the Treatment of Hypertension (REDUCE HTN:REINFORCE)
Sponsor: Boston Scientific Corporation
Industry payments
Updated 14 Oct 2026
45 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Alnylam Pharmaceuticals Inc.Program year20255 payments$15,944openpaymentsdata.cms.gov ↗
- Medtronic, Inc.Program year202512 payments
- BrioHealth Solutions, Inc.Program year20251 payment
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
61.3%Beta blocker33.6%Metoprolol Succinate28%Sotalol24%Carvedilol15%Atenolol14%Metoprolol Tartrate11%Propranolol Hcl Er8%Part D<11 patientsAntiarrhythmic14.9%Amiodarone Hcl66%Multaq34%Part D<11 patients+ 1 more class in this area
Blood & clotting
38.7%Factor Xa inhibitor26.3%Xarelto58%Eliquis43%Part D≥21 patientsDirect thrombin inhibitors9.6%Dabigatran Etexilate100%Part D≥11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Publications
Updated 14 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Three-Year Durability of Radiofrequency Renal Denervation: SPYRAL HTN-ON MED.
Journal of the American Heart Association
Clinical Trial2026 - Aprocitentan in Patients With Chronic Kidney Disease and Resistant Hypertension.
Hypertension (Dallas, Tex.
Clinical Trial2026 - On-treatment systolic blood pressure and preserved kidney function in hypertensive patients with proteinuria. The VALUE Trial.
Blood pressure
Clinical Trial2025 - Low Achieved Systolic Blood Pressure Related to Kidney Protection in Diabetic and Non-Diabetic High-Risk Hypertensive Patients.
American journal of hypertension
Clinical Trial2025 - Overcoming Barriers to Developing and Implementing Novel Therapies for Hypertension.
Hypertension (Dallas, Tex.
Review2025
Online presence
Updated 14 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Other
doctormichaelweber.com
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doctormichaelweber.com ↗ - ResearchGate
researchgate.net/scientific-contributions/Michael-A-Weber-MD-2034514207
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
Mentions by others
where others cite or feature them- Other
ish-world.com/portfolio/michael-weber-usa
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ish-world.com ↗ - YouTube
youtube.com/watch
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 14 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- MB BS (Bachelor of Medicine, Bachelor of Surgery) and MD
University of Sydney, Australia
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →24-7pressrelease.com ↗
Editorial & leadership roles
journal and society appointments- Editor-in-chief
The Journal of Clinical Hypertension
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →downstate.edu ↗ - Founding member and past president
American Society of Hypertension (ASH); former chair, ASH Hypertension Specialists Program
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →downstate.edu ↗ - Fellow
American College of Physicians; Fellow, American College of Cardiology; Fellow, American Heart Association
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →downstate.edu ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →24-7pressrelease.com ↗
Media & interviews
press, podcasts and appearances- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →hcplive.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →patientcareonline.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →medscape.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
John Danias, MD, PhD
SUNY Downstate Health Sciences University
Howard Crystal, MD
SUNY Downstate Health Sciences University
Ovadia Abulafia, MD
SUNY Downstate Health Sciences University
Michael Augenbraun, MD
SUNY Downstate Health Sciences University
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Scott Solomon, MD
Brigham and Women's Hospital
Eric Topol, MD
Scripps Research Institute (Scripps Research)